Patents by Inventor Wu Yang

Wu Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10735839
    Abstract: Disclosed is a line card chassis which includes line card units, optical electrical conversion units and optical fiber interface units. The optical-electrical conversion unit has an onboard optical assembly module used for mutual conversion between an optical signal and an electrical signal; an electrical signal interface of the onboard optical assembly module is connected to the line card unit through an electrical connector, and an optical signal interface of the onboard optical assembly module is connected to the optical fiber interface unit through an optical connector; and the optical fiber interface unit couples the optical signal to a cluster interface of a panel on a router through an optical fiber, and the cluster interface is to concatenate different chassis in the router. Also disclosed is a multi-chassis cluster router and a packet processing method.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: August 4, 2020
    Assignee: New H3C Technologies Co., Ltd.
    Inventor: Wu Yang
  • Patent number: 10654860
    Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: May 19, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: Wu Yang, Peter W. Glunz, Rajeev S. Bhide, Kamalraj Thiyagarajan
  • Publication number: 20200131200
    Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
    Type: Application
    Filed: January 10, 2020
    Publication date: April 30, 2020
    Inventors: Leon M. Smith, II, Vladimir Ladziata, Indawati De Lucca, Donald J.P. Pinto, Michael J. Orwat, Andrew K. Dilger, Kumar Balashnmuga Pabbisetty, Wu Yang, Scott A. Shaw, Peter W. Glunz, Manoranjan Panda
  • Publication number: 20200122897
    Abstract: A ring-peel-seal liner is revealed, the ring-peel-seal liner includes a metal sealing layer and an adhesive layer. The metal sealing layer has a first annular tear line, and is defined into an annular region and a central region by the first annular tear line, wherein the annular region encircles the central region. The adhesive layer is adhered on one surface of the metal sealing layer. With the ring-peel-seal liner described above, the issue of needing an additional liner for enhancing a sealing effect after opening a conventional packaging container is resolved.
    Type: Application
    Filed: October 17, 2019
    Publication date: April 23, 2020
    Inventor: YEN-WU YANG
  • Patent number: 10611776
    Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: April 7, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: Leon M. Smith, II, Vladimir Ladziata, Indawati De Lucca, Donald J. P. Pinto, Michael J. Orwat, Andrew K. Dilger, Kumar Balashanmuga Pabbisetty, Wu Yang, Scott A. Shaw, Peter W. Glunz, Manoranjan Panda
  • Publication number: 20200087312
    Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: November 21, 2019
    Publication date: March 19, 2020
    Inventors: James R. Corte, Tianan Fang, Carl P. Decicco, Donald J.P. Pinto, Karen A. Rossi, Zilun Hu, Yoon Jeon, Mimi L. Quan, Joanne M. Smallheer, Yufeng Wang, Wu Yang
  • Publication number: 20200055854
    Abstract: The present invention provides compounds of Formula (1): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: June 25, 2019
    Publication date: February 20, 2020
    Inventors: Andrew K. Dilger, James R. Corte, Indawati De Lucca, Tianan Fang, Wu Yang, Yufeng Wang, Kumar Balashanmuga Pabbisetty, William R. Ewing, Yeheng Zhu, Ruth R. Wexler, Donald J.P. Pinto, Michael J. Orwat, Leon M. Smith, II
  • Publication number: 20200018896
    Abstract: An anti-cracking panda-type polarization-maintaining optical fiber includes a cladding layer, stress layers, and a fiber core. The fiber core is located in the center of the cladding layer. The stress layers are located symmetrically at two sides of the fiber core with a distance away from the fiber core and are located within the cladding layer. Each stress layer is enclosed at edges of their outer sides by a transition layer with a gradient refractive index. By providing the transition layer with the gradient refractive index at the edge of the outer side of the stress layer, the pressure stress at the edge of the stress layer is decomposed and released, so as to avoid cracks at the edge of the polished stress layer on the end of the optical fiber, and thus optimizes the performance of the polarization-maintaining optical fiber by decreasing the room temperature polishing cracking rate.
    Type: Application
    Filed: September 19, 2017
    Publication date: January 16, 2020
    Inventors: Kun YANG, Weijun TONG, Beibei CAO, Wu YANG, Gaoqing LEI, Xinben ZHANG, Zhendong WANG, Wei ZHENG, Yilin TONG
  • Publication number: 20200018895
    Abstract: A high bandwidth radiation-resistant multimode optical fiber includes a core and a cladding layer surrounding the core. The core is a fluorine-doped quartz glass layer with a graded refractive index distribution and a distribution power exponent ? of 1.7-2.2. The core has R1 of 15-35 ?m and ?1%min of ?0.8% to ?1.2%. The cladding layer has an inner cladding layer having R2 of 15-38 ?m and ?2% of ?0.8% to ?1.2% and/or a depressed inner cladding layer having R3 of 15-55 ?m and ?3 of ?1.0% to ?1.4%, an intermediate cladding layer having R4 of 15.5-58 ?m and ?4 of ?0.7% to ?0.2% a depressed cladding layer hasving R5 of 16-60 ?m and ?5 of ?0.8% to ?1.2%, and an outer cladding layer sequentially formed from inside to outside. The outer cladding layer is a pure silica glass layer.
    Type: Application
    Filed: November 8, 2017
    Publication date: January 16, 2020
    Inventors: Wei Zheng, Gaoqing LEI, Wu YANG
  • Patent number: 10520326
    Abstract: A driving route matching method, apparatus, and storage medium. The method includes: obtaining a route to be retrieved, the route including a retrieval start point and a retrieval end point; performing a search in a database of existing routes, and selecting the existing routes passing through grids within a predetermined range around the start point as routes available for the start point; performing a search in the database of the existing routes, and selecting the existing routes passing through grids within a predetermined range around the search endpoint as routes available for the end point; calculating intersections of the routes available for the start point and the routes available for the end point, and using the routes in the intersections as candidate routes; and screening the candidate routes according to detouring distances. The driving route matching method and apparatus enable a remarkable improvement in the efficiency of driving route matching.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: December 31, 2019
    Assignee: Baidu Online Network Technology (Beijing) Co., Ltd.
    Inventors: Xiaoyang Sun, Wu Yang, Yu Zhi, Changcheng Zhou
  • Patent number: 10487086
    Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: November 26, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: James R. Corte, Tianan Fang, Carl P. Decicco, Donald J. P. Pinto, Karen A. Rossi, Zilun Hu, Yoon Jeon, Mimi L. Quan, Joanne M. Smallheer, Yufeng Wang, Wu Yang
  • Publication number: 20190276466
    Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
    Type: Application
    Filed: November 29, 2017
    Publication date: September 12, 2019
    Inventors: Wu Yang, Peter W. Glunz, Rajeev S. Bhide, Kamalraj Thiyagarajan
  • Publication number: 20190253777
    Abstract: Disclosed is a line card chassis which includes line card units, optical electrical conversion units and optical fiber interface units. The optical-electrical conversion unit has an onboard optical assembly module used for mutual conversion between an optical signal and an electrical signal; an electrical signal interface of the onboard optical assembly module is connected to the line card unit through an electrical connector, and an optical signal interface of the onboard optical assembly module is connected to the optical fiber interface unit through an optical connector; and the optical fiber interface unit couples the optical signal to a cluster interface of a panel on a router through an optical fiber, and the cluster interface is to concatenate different chassis in the router. Also disclosed is a multi-chassis cluster router and a packet processing method.
    Type: Application
    Filed: November 24, 2016
    Publication date: August 15, 2019
    Inventor: Wu YANG
  • Publication number: 20190227569
    Abstract: Systems and methods are directed to a task management platform for managing autonomous vehicles. In one example, a computer-implemented method for managing a fleet of vehicles includes obtaining, by a computing system comprising one or more computing devices, vehicle state data indicative of vehicle state from one or more vehicles among a fleet of vehicles. The method further includes determining, by the computing system, if a vehicle event has occurred based at least in part on the vehicle state data. The method further includes in response to determining a vehicle event has occurred, generating, by the computing system, one or more tasks for resolution of the vehicle event, wherein the one or more tasks include data associated with the one or more vehicles and the vehicle event. The method further includes providing, by the computing system, data associated with the one or more tasks to a remote operator computing system.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 25, 2019
    Inventors: Emily Anna Weslosky, Gary Wu Yang, Nuri Kim, Anand Nandakumar, Varun Rau, Mark Russell Reeder, Robert Eperjesi
  • Publication number: 20190220036
    Abstract: Systems and methods for managing a fleet of vehicles are provided. In one example embodiment, a computer-implemented method includes obtaining data representing vehicle state information associated with one or more vehicles among a fleet of vehicles at one or more times. The method includes predicting a future vehicle state associated with the one or more vehicles at one or more future times. The method includes scheduling a vehicle assignment in a predetermined set of vehicle assignments for a selected vehicle among the one or more vehicles before a first future time among the one or more future times. The method includes transmitting a command signal to a computing system associated with the selected vehicle based at least in part on the scheduled vehicle assignment.
    Type: Application
    Filed: February 19, 2018
    Publication date: July 18, 2019
    Inventors: Emily Anna Weslosky, Gary Wu Yang, Nuri Kim, Lili Kan, Varun Rau, Xiaoman Dong, Julie Marie Derence, Christopher John Peplin, Daniel Joseph Tascione, Steve Ayers, Mark Reeder, Robert Eperjesi, Richard Tom, Steven Hanby Williams, Venkata Sathya Praveen Gorthy, Sunil Kumar Garg, Chris Lyons, Yi Shi
  • Publication number: 20190202808
    Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are biased agonists, or ?-Arrestin agonists of the angiotensin II receptor, which may be used as medicaments.
    Type: Application
    Filed: June 28, 2017
    Publication date: July 4, 2019
    Inventors: Eldon Scott PRIESTLEY, Samuel Kaye REZNIK, Edward H. RUEDIGER, James R. GILLARD, Oz Scott HALPERN, Wen JIANG, Jeremy RICHTER, Rejean RUEL, Sasmita TRIPATHY, Wu YANG, Xiaojun ZHANG
  • Patent number: 10336754
    Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: July 2, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: Andrew K. Dilger, James R. Corte, Indawati De Lucca, Tianan Fang, Wu Yang, Yufeng Wang, Kumar Balashanmuga Pabbisetty, William R. Ewing, Yeheng Zhu, Ruth R. Wexler, Donald J. P. Pinto, Michael J. Orwat, Leon M. Smith, II
  • Patent number: 10311268
    Abstract: Embodiments of the present disclosure relate to adaptive RFID communication. A tag device includes a storage configured to store content that is executable by a proxy device associated with a reader device. The tag device includes a communication component configured to transmit the content to the reader device, the content, when executed by the proxy device, causing an action associated with the tag device to be performed.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: June 4, 2019
    Assignee: International Business Machines Corporation
    Inventors: Liang He, Zhen Duo Liu, Chun Lei Xu, Geng Wu Yang, Feng Zheng
  • Publication number: 20190144393
    Abstract: The present invention provides compounds of Formula (I): P-Ma??(I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: January 11, 2019
    Publication date: May 16, 2019
    Inventors: James R. Corte, Andrew K. Dilger, William R. Ewing, Donald J.P. Pinto, Wu Yang
  • Patent number: D899093
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: October 20, 2020
    Assignee: Colgate-Palomolive Company
    Inventors: Takahide Okai, Wu Yang